BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/14/2017 11:43:15 AM | Browse: 836 | Download: 1252
 |
Received |
|
2017-02-07 18:46 |
|
Peer-Review Started |
|
2017-02-12 23:11 |
|
To Make the First Decision |
|
2017-03-08 09:41 |
|
Return for Revision |
|
2017-03-10 17:19 |
|
Revised |
|
2017-03-17 13:29 |
|
Second Decision |
|
2017-03-29 10:09 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2017-04-10 09:07 |
|
Articles in Press |
|
2017-04-10 09:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-05-26 09:54 |
|
Publish the Manuscript Online |
|
2017-06-14 11:43 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Case Report |
| Article Title |
Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Puneet Gandhi, Richa Khare, Nitin Garg and Sandeep K Sorte |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| M.P. Biotech Council, M.P. for financial assistance and BMHRC for infrastructural facilities |
249 |
|
| Corresponding Author |
Dr. Puneet Gandhi, Professor, Head, Department of Research, Bhopal Memorial Hospital and Research Centre, Raisen Bypass Road, Bhopal 462038,
India. puneetgandhi67@yahoo.com |
| Key Words |
Glioblastoma multiforme; Immunophenotypic signature; Progression free survival; Molecular markers; Human telomerase reverse transcriptase; Interleukin-6; Tissue inhibitor of metalloproteinases-1; YKL-40; High mobility group-A1 |
| Core Tip |
Delineating the immunophenotypic signature for glioblastoma with reference to disease progression is of clinical importance. This case report presents for the first time a panel of 6 systemic molecular markers in circulation namely; human telomerase reverse transcriptase, interleukin-6, neutrophil-lymphocyte ratio, tissue inhibitor of metalloproteinases-1, human chitinase-3-like-protein-1 and high mobility group-A1 representing the mechanistic of inflammation, proliferation and invasion of the tumor. Their expression is suggested to be linked to progression-free survival in glioblastoma-multiforme. |
| Publish Date |
2017-06-14 11:43 |
| Citation |
Gandhi P, Khare R, Garg N, Sorte S. Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival. World J Clin Cases 2017; 5(6): 247-253 |
| URL |
http://www.wjgnet.com/2307-8960/full/v5/i6/247.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v5.i6.247 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
